EMA Issues Advice on Regeneron’s Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
- Friday, February 26, 2021, 7:14
- PR Newswire
- Add a comment
TARRYTOWN, N.Y., Feb. 26, 2021 /PRNewswire/ — EU member states can utilize the positive CHMP opinion when making national decisions about use of the antibody cocktail, prior to a potential future EMA market authorization Regeneron has collaborated with Roche to develop and manufacture…
About the Author
admin has written 21630 stories on this site.